The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Longitudinal Follow-up and Outcomes Among a Population With Chronic Kidney Disease in a Large Managed Care Organization
Abstract
BACKGROUND: Chronic kidney disease is the primary cause of end-stage renal disease in the United States. The purpose of this study was to understand the natural history of chronic kidney disease with regard to progression to renal replacement therapy (transplant or dialysis) and death in a representative patient population. METHODS: In 1996 we identified 27 998 patients in our health plan who had estimated glomerular filtration rates of less than 90 mL/min per 1.73 m(2) on 2 separate measurements at least 90 days apart. We followed up patients from the index date of the first glomerular filtration rates of less than 90 mL/min per 1.73 m(2) until renal replacement therapy, death, disenrollment from the health plan, or June 30, 2001. We extracted from the computerized medical records the prevalence of the following comorbidities at the index date and end point: hypertension, diabetes mellitus, coronary artery disease, congestive heart failure, hyperlipidemia, and renal anemia. RESULTS: Our data showed that the rate of renal replacement therapy over the 5-year observation period was 1.1%, 1.3%, and 19.9%, respectively, for the National Kidney Foundation Kidney Disease Outcomes Quality Initiative (K/DOQI) stages 2, 3, and 4, but that the mortality rate was 19.5%, 24.3%, and 45.7%. Thus, death was far more common than dialysis at all stages. In addition, congestive heart failure, coronary artery disease, diabetes, and anemia were more prevalent in the patients who died but hypertension prevalence was similar across all stages. CONCLUSION: Our data suggest that efforts to reduce mortality in this population should be focused on treatment and prevention of coronary artery disease, congestive heart failure, diabetes mellitus, and anemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gerstein, H. C. (2001) · JAMA · doi:10.1001/jama.286.4.421 · Cited by 2,440
Peterson, J. C., Adler, S., Burkart, J. M., Greene, T., Hebert, L. A., Hunsicker, L. G., King, A. J., Klahr, S., Massry, S. G., Seifter, J. L., et al. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-10-199511150-00003 · Cited by 1,342
Port, F. K., Hulbert-Shearon, T. E., Wolfe, R. A., Bloembergen, W. E., Golper, T. A., Agodoa, L. Y. C., & Young, E. W. (1999) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(99)70188-5 · Cited by 451
C-reactive protein as an outcome predictor for maintenance hemodialysis patients
Owen, W. F. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00032.x · Cited by 378
Prediction equations to estimate glomerular filtration rate: an update
Manjunath, G., Sarnak, M. J., & Levey, A. S. (2001) · Current Opinion in Nephrology and Hypertension · doi:10.1097/00041552-200111000-00009 · Cited by 277
Blood pressure and mortality in elderly people aged 85 and older: community based study
Boshuizen, H. C., Izaks, G. J., van Buuren, S., & Ligthart, G. J. (1998) · BMJ · doi:10.1136/bmj.316.7147.1780 · Cited by 196
Menotti, A., Mulder, I., Nissinen, A., Feskens, E., Giampaoli, S., Tervahauta, M., & Kromhout, D. (2001) · European Heart Journal · doi:10.1053/euhj.2000.2402 · Cited by 103
Blood pressure and cardiovascular morbidity and mortality rates in the elderly
Kannel, W. B., D’Agostino, R. B., & Silbershatz, H. (1997) · American Heart Journal · doi:10.1016/s0002-8703(97)70061-9 · Cited by 89
Casiglia, E., Mazza, A., Tikhonoff, V., Pavei, A., Privato, G., Schenal, N., & Pessina, A. C. (2002) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001288 · Cited by 50
Cited by
Prevalence of Chronic Kidney Disease in the United States
Coresh, J., Selvin, E., Stevens, L. A., Manzi, J., Kusek, J. W., Eggers, P., Van Lente, F., & Levey, A. S. (2007) · JAMA · doi:10.1001/jama.298.17.2038 · Cited by 4,895
“buminuria is the strongest risk factor for CKD progression, it is also associated with an increased risk of cardiovascular morbidity and mortality.(13) Chronic kidney disease stages 3 and 4 are marked by complications of reduced GFR.”
BackgroundChronic kidney disease: global dimension and perspectives
Jha, V., Garcia-Garcia, G., Iseki, K., Li, Z., Naicker, S., Plattner, B., Saran, R., Wang, A. Y.-M., & Yang, C.-W. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60687-x · Cited by 4,383
Webster, A. C., Nagler, E. V., Morton, R. L., & Masson, P. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32064-5 · Cited by 3,842
Assessing Kidney Function — Measured and Estimated Glomerular Filtration Rate
Stevens, L. A., Coresh, J., Greene, T., & Levey, A. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmra054415 · Cited by 2,952
Ronco, C., Haapio, M., House, A. A., Anavekar, N., & Bellomo, R. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.07.051 · Cited by 1,883
Chronic Kidney Disease Diagnosis and Management: A Review
Chen, T. K., Knicely, D. H., & Grams, M. E. (2019) · JAMA · doi:10.1001/jama.2019.14745 · Cited by 1,811
Levey, A. S., Atkins, R., Coresh, J., Cohen, E. P., Collins, A. J., Eckardt, K.-U., Nahas, M. E., Jaber, B. L., Jadoul, M., Levin, A., et al. (2007) · Kidney International · doi:10.1038/sj.ki.5002343 · Cited by 1,516
The contribution of chronic kidney disease to the global burden of major noncommunicable diseases
Couser, W. G., Remuzzi, G., Mendis, S., & Tonelli, M. (2011) · Kidney International · doi:10.1038/ki.2011.368 · Cited by 1,513
Levin, A., Bakris, G. L., Molitch, M., Smulders, M., Tian, J., Williams, L. A., & Andress, D. L. (2007) · Kidney International · doi:10.1038/sj.ki.5002009 · Cited by 1,513
on behalf of The Japanese Society of Hypertension Committee for Guidelines for the Management of Hypertension, Ogihara, T., Kikuchi, K., Matsuoka, H., Fujita, T., Higaki, J., Horiuchi, M., Imai, Y., Imaizumi, T., Ito, S., et al. (2014) · Hypertension Research · doi:10.1038/hr.2014.68 · Cited by 1,385
Body Mass Index and Risk for End-Stage Renal Disease
Hsu, C.-Y., McCulloch, C. E., Iribarren, C., Darbinian, J., & Go, A. S. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-1-200601030-00006 · Cited by 1,390
A Predictive Model for Progression of Chronic Kidney Disease to Kidney Failure
Tangri, N. (2011) · JAMA · doi:10.1001/jama.2011.451 · Cited by 1,348
Humphreys, B. D. (2018) · Annual Review of Physiology · doi:10.1146/annurev-physiol-022516-034227 · Cited by 1,231
Prevalence of chronic kidney disease in population-based studies: Systematic review
Zhang, Q.-L., & Rothenbacher, D. (2008) · BMC Public Health · doi:10.1186/1471-2458-8-117 · Cited by 1,021
Matsushita, K., Mahmoodi, B. K., Woodward, M., Emberson, J. R., Jafar, T. H., Jee, S. H., Polkinghorne, K. R., Shankar, A., Smith, D. H., Tonelli, M., et al. (2012) · JAMA · doi:10.1001/jama.2012.3954 · Cited by 988
Self-citationSchmidli, J., Widmer, M. K., Basile, C., de Donato, G., Gallieni, M., Gibbons, C. P., Haage, P., Hamilton, G., Hedin, U., Kamper, L., et al. (2018) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2018.02.001 · Cited by 878
Henske, E. P., Jóźwiak, S., Kingswood, J. C., Sampson, J. R., & Thiele, E. A. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.35 · Cited by 831
Age Affects Outcomes in Chronic Kidney Disease
O'Hare, A. M., Choi, A. I., Bertenthal, D., Bacchetti, P., Garg, A. X., Kaufman, J. S., Walter, L. C., Mehta, K. M., Steinman, M. A., Allon, M., et al. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007040422 · Cited by 747
Tyson, C. C., & Coffman, T. M. (2017) · Nephron · doi:10.1159/000455130 · Cited by 710
The Frequency of Hyperkalemia and Its Significance in Chronic Kidney Disease
Einhorn, L. M., Zhan, M., Hsu, V. D., Walker, L. D., Moen, M. F., Seliger, S. L., Weir, M. R., & Fink, J. C. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.132 · Cited by 646
Age and Association of Kidney Measures With Mortality and End-stage Renal Disease
Hallan, S. I., Matsushita, K., Sang, Y., Mahmoodi, B. K., Black, C., Ishani, A., Kleefstra, N., Naimark, D., Roderick, P., Tonelli, M., et al. (2012) · JAMA · doi:10.1001/jama.2012.16817 · Cited by 636
JBS3 Board (2014) · Heart · doi:10.1136/heartjnl-2014-305693 · Cited by 608
Survival advantages of obesity in dialysis patients
Kalantar-Zadeh, K., Abbott, K. C., Salahudeen, A. K., Kilpatrick, R. D., & Horwich, T. B. (2005) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/81.3.543 · Cited by 610
Early recognition and prevention of chronic kidney disease
James, M. T., Hemmelgarn, B. R., & Tonelli, M. (2010) · The Lancet · doi:10.1016/s0140-6736(09)62004-3 · Cited by 606
Eriksen, B. O., & Ingebretsen, O. C. (2006) · Kidney International · doi:10.1038/sj.ki.5000058 · Cited by 576
Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences
Vaziri, N. D. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00099.2005 · Cited by 538
Iron deficiency anaemia revisited
Cappellini, M. D., Musallam, K. M., & Taher, A. T. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13004 · Cited by 508
Cappellini, M. D., Comin‐Colet, J., de Francisco, A., Dignass, A., Doehner, W., Lam, C. S., Macdougall, I. C., Rogler, G., Camaschella, C., Kadir, R., et al. (2017) · American Journal of Hematology · doi:10.1002/ajh.24820 · Cited by 502
Timing of Onset of CKD-Related Metabolic Complications
Moranne, O., Froissart, M., Rossert, J., Gauci, C., Boffa, J.-J., Haymann, J. P., M’rad, M. B., Jacquot, C., Houillier, P., Stengel, B., et al. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008020159 · Cited by 478
Zakai, N. A., Katz, R., Hirsch, C., Shlipak, M. G., Chaves, P. H. M., Newman, A. B., & Cushman, M. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.19.2214 · Cited by 459
FGF-23 Associates with Death, Cardiovascular Events, and Initiation of Chronic Dialysis
Kendrick, J., Cheung, A. K., Kaufman, J. S., Greene, T., Roberts, W. L., Smits, G., & Chonchol, M. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010121224 · Cited by 448
Chronic kidney disease management in the United Kingdom: NEOERICA project results
Stevens, P. E., O'Donoghue, D. J., de Lusignan, S., Van Vlymen, J., Klebe, B., Middleton, R., Hague, N., New, J., & Farmer, C. K. T. (2007) · Kidney International · doi:10.1038/sj.ki.5002273 · Cited by 434
Guidelines for the management of chronic kidney disease
Levin, A., Hemmelgarn, B., Culleton, B., Tobe, S., McFarlane, P., Ruzicka, M., Burns, K., Manns, B., White, C., Madore, F., et al. (2008) · Canadian Medical Association Journal · doi:10.1503/cmaj.080351 · Cited by 420
Management of Hypertension in Chronic Kidney Disease
Pugh, D., Gallacher, P. J., & Dhaun, N. (2019) · Drugs · doi:10.1007/s40265-019-1064-1 · Cited by 401
Arterial stiffness and pulse pressure in CKD and ESRD
Briet, M., Boutouyrie, P., Laurent, S., & London, G. M. (2012) · Kidney International · doi:10.1038/ki.2012.131 · Cited by 392
Mehdi, U. F., Adams-Huet, B., Raskin, P., Vega, G. L., & Toto, R. D. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009070737 · Cited by 388
Progression of kidney dysfunction in the community-dwelling elderly
Hemmelgarn, B. R., Zhang, J., Manns, B. J., Tonelli, M., Larsen, E., Ghali, W. A., Southern, D. A., McLaughlin, K., Mortis, G., & Culleton, B. F. (2006) · Kidney International · doi:10.1038/sj.ki.5000270 · Cited by 385
Obesity Paradox in End-Stage Kidney Disease Patients
Park, J., Ahmadi, S.-F., Streja, E., Molnar, M. Z., Flegal, K. M., Gillen, D., Kovesdy, C. P., & Kalantar-Zadeh, K. (2014) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2013.10.005 · Cited by 381
Zoccali, C., Mallamaci, F., Adamczak, M., de Oliveira, R. B., Massy, Z. A., Sarafidis, P., Agarwal, R., Mark, P. B., Kotanko, P., Ferro, C. J., et al. (2023) · Cardiovascular Research · doi:10.1093/cvr/cvad083 · Cited by 363
Chronic kidney disease: a public health priority and harbinger of premature cardiovascular disease
Stenvinkel, P. (2010) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02269.x · Cited by 332
Hallan, S. I., Dahl, K., Oien, C. M., Grootendorst, D. C., Aasberg, A., Holmen, J., & Dekker, F. W. (2006) · BMJ · doi:10.1136/bmj.39001.657755.be · Cited by 330
Dyslipidaemia in nephrotic syndrome: mechanisms and treatment
Agrawal, S., Zaritsky, J. J., Fornoni, A., & Smoyer, W. E. (2018) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.155 · Cited by 325
Risk factor paradox in wasting diseases
Kalantar-Zadeh, K., Horwich, T. B., Oreopoulos, A., Kovesdy, C. P., Younessi, H., Anker, S. D., & Morley, J. E. (2007) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e3281a30594 · Cited by 309
Newsome, B. B. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.6.609 · Cited by 302
Prevalence and Factors Associated With CKD: A Population Study From Beijing
Zhang, L., Zhang, P., Wang, F., Zuo, L., Zhou, Y., Shi, Y., Li, G., Jiao, S., Liu, Z., Liang, W., et al. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2007.11.009 · Cited by 297
Cardiovascular Complications of Diabetic Kidney Disease
Pálsson, R., & Patel, U. D. (2014) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2014.03.003 · Cited by 292
Stevens, L. A., Li, S., Wang, C., Huang, C., Becker, B. N., Bomback, A. S., Brown, W. W., Burrows, N. R., Jurkovitz, C. T., McFarlane, S. I., et al. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.09.035 · Cited by 281
Renal Association Clinical Practice Guideline on Haemodialysis
Ashby, D., Borman, N., Burton, J., Corbett, R., Davenport, A., Farrington, K., Flowers, K., Fotheringham, J., Andrea Fox, R. N., Franklin, G., et al. (2019) · BMC Nephrology · doi:10.1186/s12882-019-1527-3 · Cited by 277
Ma, F., Sun, T., Liu, L., & Jing, H. (2020) · Future Generation Computer Systems · doi:10.1016/j.future.2020.04.036 · Cited by 276
White, S. L., Polkinghorne, K. R., Atkins, R. C., & Chadban, S. J. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.12.011 · Cited by 272
Iron Deficiency Anemia in Chronic Kidney Disease
Gafter-Gvili, A., Schechter, A., & Rozen-Zvi, B. (2019) · Acta Haematologica · doi:10.1159/000496492 · Cited by 265
Walsh, M., Casian, A., Flossmann, O., Westman, K., Höglund, P., Pusey, C., & Jayne, D. R. W. (2013) · Kidney International · doi:10.1038/ki.2013.131 · Cited by 264
Chronic Kidney Disease and the Risk of End-Stage Renal Disease versus Death
Dalrymple, L. S., Katz, R., Kestenbaum, B., Shlipak, M. G., Sarnak, M. J., Stehman-Breen, C., Seliger, S., Siscovick, D., Newman, A. B., & Fried, L. (2011) · Journal of General Internal Medicine · doi:10.1007/s11606-010-1511-x · Cited by 262
Structural and functional changes in the kidneys of high-fat diet-induced obese mice
Deji, N., Kume, S., Araki, S.-I., Soumura, M., Sugimoto, T., Isshiki, K., Chin-Kanasaki, M., Sakaguchi, M., Koya, D., Haneda, M., et al. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00110.2008 · Cited by 262
Craver, L., Marco, M. P., Martinez, I., Rue, M., Borras, M., Martin, M. L., Sarro, F., Valdivielso, J. M., & Fernandez, E. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfl718 · Cited by 262
Toussaint, N. D., Lau, K. K., Strauss, B. J., Polkinghorne, K. R., & Kerr, P. G. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm660 · Cited by 258
Sallée, M., Dou, L., Cerini, C., Poitevin, S., Brunet, P., & Burtey, S. (2014) · Toxins · doi:10.3390/toxins6030934 · Cited by 255
Sabbagh, Y., Graciolli, F. G., O'Brien, S., Tang, W., dos Reis, L. M., Ryan, S., Phillips, L., Boulanger, J., Song, W., Bracken, C., et al. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1630 · Cited by 254
. Prediction, progression and outcomes of chronic kidney disease in older adults.
Anderson, S., Halter, J. B., Hazzard, W. R., Himmelfarb, J., Horne, F. M., Kaysen, G. A., Kusek, J. W., Nayfield, S. G., Schmader, K., Tian, Y., et al. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008080860 · Cited by 218
Packham, D. K., Alves, T. P., Dwyer, J. P., Atkins, R., de Zeeuw, D., Cooper, M., Shahinfar, S., Lewis, J. B., & Lambers Heerspink, H. J. (2012) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2011.09.017 · Cited by 205
Incretin drugs in diabetic kidney disease: biological mechanisms and clinical evidence
Alicic, R. Z., Cox, E. J., Neumiller, J. J., & Tuttle, K. R. (2021) · Nature Reviews Nephrology · doi:10.1038/s41581-020-00367-2 · Cited by 193
Collins, G. S., Omar, O., Shanyinde, M., & Yu, L.-M. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2012.06.020 · Cited by 192
The associations of plant protein intake with all-cause mortality in CKD
Chen, X., Wei, G., Jalili, T., Metos, J., Giri, A., Cho, M. E., Boucher, R., Greene, T., & Beddhu, S. (2016) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2015.10.018 · Cited by 187
Failure of ICD‐9‐CM Codes to Identify Patients with Comorbid Chronic Kidney Disease in Diabetes
Kern, E. F. O., Maney, M., Miller, D. R., Tseng, C., Tiwari, A., Rajan, M., Aron, D., & Pogach, L. (2006) · Health Services Research · doi:10.1111/j.1475-6773.2005.00482.x · Cited by 165
Kuznik, A., Mardekian, J., & Tarasenko, L. (2013) · BMC Nephrology · doi:10.1186/1471-2369-14-132 · Cited by 86
Campbell, K. L., Ash, S., Davies, P. S. W., & Bauer, J. D. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2007.12.015 · Cited by 85
Chonchol, M., Cook, T., Kjekshus, J., Pedersen, T. R., & Lindenfeld, J. (2007) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.11.043 · Cited by 76
Iron regulatory protein 1 promotes ferroptosis by sustaining cellular iron homeostasis in melanoma
Yao, F., Cui, X., Zhang, Y., Bei, Z., Wang, H., Zhao, D., Wang, H., & Yang, Y. (2021) · Oncology Letters · doi:10.3892/ol.2021.12918 · Cited by 75
Yamamoto, S., Zuo, Y., Ma, J., Yancey, P. G., Hunley, T. E., Motojima, M., Fogo, A. B., Linton, M. F., Fazio, S., Ichikawa, I., et al. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq759 · Cited by 74
“Indeed, the risk of premature cardiovascular disease (CVD) death in patients with CKD is much higher than the risk of progressing to dialysis or transplantation [3, 4].”
BackgroundZivkovic, A. M., Wiest, M. M., Nguyen, U., Nording, M. L., Watkins, S. M., & German, J. B. (2009) · Metabolomics · doi:10.1007/s11306-008-0136-0 · Cited by 63
“For instance, in end-stage renal disease, although up to 20% of patients may need kidney transplant over 5 years, the most immediate health concern is actually the high mortality rate (up to 45% of patients) associated with cardiovascular disease and diabetes, both of which are strongly associated with dyslipidemia (…”
BackgroundGeriatric Nephrology: Responding to a Growing Challenge
Rosner, M., Abdel-Rahman, E., & Williams, M. E. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.08731209 · Cited by 56
Physical inactivity and chronic kidney disease in Australian adults: The AusDiab study
White, S. L., Dunstan, D. W., Polkinghorne, K. R., Atkins, R. C., Cass, A., & Chadban, S. J. (2011) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2009.08.010 · Cited by 55
Safety of liraglutide in type 2 diabetes and chronic kidney disease
Mann, J. F. E., Fonseca, V. A., Poulter, N. R., Raz, I., Idorn, T., Rasmussen, S., von Scholten, B. J., Mosenzon, O., & on behalf of the LEADER Trial Investigators (2020) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.11881019 · Cited by 50
Lerma, E., White, W. B., & Bakris, G. (2023) · Postgraduate Medicine · doi:10.1080/00325481.2022.2060598 · Cited by 39
Sprick, J. D., Mammino, K., Jeong, J., DaCosta, D. R., Hu, Y., Morison, D. G., Nocera, J. R., & Park, J. (2022) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00808.2021 · Cited by 28
Does lipid-lowering therapy slow progression of chronic kidney disease?
Wheeler, D. C. (2004) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(04)01139-4 · Cited by 11
Frostegård, A. G., Hua, X., Su, J., Carrero, J. J., Heimbürger, O., Bárány, P., Stenvinkel, P., & Frostegård, J. (2013) · Clinical and Experimental Immunology · doi:10.1111/cei.12181 · Cited by 7
Metadata
- Authors
- Keith, D. S., Nichols, G. A., Gullion, C. M., Brown, J. B., & Smith, D. H.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2004-03-22
- Volume
- 164
- Issue
- 6
- Pages
- 659
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W2091886687
- Cited by
- 1,684
- References
- 9
- FWCI
- 38.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.